Therefore, it is conceivable that PLK2 is tumor suppressive in breast cancer, specifically that chromosomal loss of PLK2 is highly enriched within the basal-like/triple-negative subtypes of breast cancer. The gene discussed is PLK2; the disease is breast cancer.